Cargando…
Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers
c-Myc is a master regulator of various oncogenic functions in many types of human cancers. However, direct c-Myc-targeted therapy has not been successful in the clinic. Here, we explored a novel therapeutic target, which shows synthetic lethality in c-Myc-driven ovarian cancers, and examined the mol...
Autores principales: | Hasegawa-Minato, Junko, Toyoshima, Masafumi, Ishibashi, Masumi, Zhang, Xuewei, Shigeta, Shogo, Grandori, Carla, Kitatani, Kazuyuki, Yaegashi, Nobuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790477/ https://www.ncbi.nlm.nih.gov/pubmed/29423060 http://dx.doi.org/10.18632/oncotarget.23322 |
Ejemplares similares
-
Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer
por: Ishibashi, Masumi, et al.
Publicado: (2018) -
Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer
por: Zhang, Xuewei, et al.
Publicado: (2020) -
Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid
por: Kitatani, Kazuyuki, et al.
Publicado: (2015) -
The proprotein convertase furin is required for trophoblast syncytialization
por: Zhou, Z, et al.
Publicado: (2013) -
Increased Expression of the Pro-Protein Convertase Furin Predicts Decreased Survival in Ovarian Cancer
por: Page, Robert E., et al.
Publicado: (2007)